Blog
Why Arcos Dorados Holdings Inc. Gained 18% Last Month
Shares of Arcos Dorados Holdings Inc. (NYSE: ARCO) jumped again last month, gaining on a strong earnings report for its franchisor and on anticipation of its own second-quarter earnings report.Image
Why TripAdvisor Inc Stock Slumped Today
Shares of TripAdvisor Inc. (NASDAQ: TRIP) were pulling back today after the travel services company reported another underwhelming earnings report and gave weak guidance.As of 11:18 a.m. EDT, the
Here's Why Acadia Pharmaceuticals Inc. Is Soaring Today
In response to Acadia Pharmaceuticals (NASDAQ: ACAD) reporting blow-out earnings and sharing upbeat guidance, shares of the commercial-stage biopharma, which focuses on diseases of the central nervous
Investors Bail on Fossil Group After Abysmal Second-Quarter Results
It hasn't been an enjoyable morning for investors of Fossil Group, Inc. (NASDAQ: FOSL), a global designer, marketer, and distributor of products that include watches, jewelry, handbags, small leather
Why Shares of Supreme Industries, Inc. Popped 36% Today
Shares of Supreme Industries, Inc. (NYSEMKT: STS) jumped as much as 35.6% in trading today after getting a buyout offer from Wabash National Corporation (NYSE: WNC). At 10:55 a.m. EDT, shares were
Why Office Depot Inc. Stock Plummeted Today
Shares of Office Depot Inc. (NASDAQ: ODP) tumbled after the retailer posted weak second-quarter results. The stock was down 22.4% as of 12:15 p.m. EDT.Image source: Getty Images.Continue readingSource
Disney: A Stream Is a Wish Your Heart Makes
It's been a year since Walt Disney (NYSE: DIS) shelled out $1 billion for a minority stake in BAMtech, and now it's putting all of the pieces together. The media giant revealed on Tuesday afternoon
Why NextEra Energy Partners Shares Popped 11% in July
Shares of yieldco NextEra Energy Partners (NYSE: NEP) jumped 11.4% in July according to data provided by S&P Global Market Intelligence after the company reported earnings for the second quarter. And
3 Things National-Oilwell Varco, Inc.'s CEO Wants You to Know
National Oilwell Varco's (NYSE: NOV) financial results continued showing signs of improvement during the second quarter. Revenue crept up both sequentially and year over year while its net loss kept
What Is Square's Competitive Advantage?
Square (NYSE: SQ) made a name for itself by developing little credit card readers that hook up to a smartphone or tablet. It made it easy for anyone to accept credit cards, from tutors to food trucks
Why Shares of TrueCar Are Down More Than 13% Today
Online car-buying facilitator TrueCar (NASDAQ: TRUE) is having a tough day on Wall Street after reporting its second-quarter earnings and revising its 2017 forecast late on Tuesday. As of 12:41 p.m
Why PetMed Express, Inc. Stock Jumped 18% in July
Shares of PetMed Express, Inc. (NASDAQ: PETS) jumped last month after the nation's largest pet pharmacy delivered a strong second-quarter earnings report. According to data from S&P Global Market
2 Reasons Behind Achillion Pharmaceuticals, Inc.'s 11% Tumble in July
Shares of Achillion Pharmaceuticals (NASDAQ: ACHN), a clinical-stage drug developer focused on small-molecule treatments for infectious diseases, such as hepatitis C, turned in a dismal July and sank
Why Achillion Pharmaceuticals Is Shooting 25% Higher Today
After the company updated investors on its second-quarter financials and the progress it's making in its clinical-stage drug pipeline, shares in Achillion Pharmaceuticals (NASDAQ: ACHN) are soaring
Tucows Inc. Shows Buyout-Powered Growth, Plans to Expand Broadband Services
Network service provider Tucows (NASDAQ: TCX) reported second-quarter results on Tuesday evening. In the first full quarter after the acquisition of domain name registrar Enom in January, Tucows
Why Priceline Stock Is Slumping Today
Share of online travel giant Priceline Group (NASDAQ: PCLN) tumbled on Wednesday despite a strong second-quarter report. Priceline's guidance seems to be the culprit, with the company calling for a
Why Impax Laboratories Inc Jumped Higher Today
Impax Laboratories (NASDAQ: IPXL) is up 7.6% at 11:53 a.m. EDT, having been up as much as 17.9% earlier today, after reporting solid second-quarter earnings.Revenue from the drugmaker was up 17% year
Why RingCentral Inc. Stock Jumped Today
Shares of RingCentral (NYSE: RNG) jumped as much as 19.9% higher Wednesday morning, thanks to unconfirmed reports that the cloud-based enterprise communications expert has attracted buyout interest
Mylan N.V. Slashes 2017 Earnings Guidance on Delays of Generic Launches
When Mylan N.V. (NASDAQ: MYL) reported its first-quarter results earlier this year, the company's year-over-year revenue and earnings comparisons were helped significantly by Mylan's acquisitions in
Analyst Picks: 2 Defense Stocks to Buy, 1 to Hold, and 1 to Sell
"[W]e haven't necessarily found [any defense companies to buy] that we found to be compelling either from a price expectation perspective or from a fit and rationale perspective." -- General Dynamics
Energy Transfer Partners LP Finally Turns the Corner
Energy Transfer Partners (NYSE: ETP) has endured its share of trials over the past year as the downturn in the oil market, as well as some operational missteps and unforeseen delays, have weighed on
Why Everi Holdings Inc. Stock Jumped 19% Today
Shares of Everi Holdings Inc. (NYSE: EVRI) are soaring, trading higher by about 19% as of 11:30 a.m. EDT on the back of better-than-expected results in its second quarter.Everi Holdings is in the
Here's Why NantKwest Inc. Tumbled 21.1% in July
Shares of NantKwest (NASDAQ: NK), a clinical-stage biotech company primarily focused on immunotherapy compounds that treat cancer, fell by 21% in July, according to S&P Global Market Intelligence. The
Improving Future Prospects Please Envestnet Shareholders
The connections that certain companies have with the industries they serve are obvious. Envestnet (NYSE: ENV) is a good example, with its financial information technology business benefiting greatly
Exelixis, Inc. Continued Its Winning Ways and Rose 10% in July Thanks to These 3 Catalysts
Shares of Exelixis (NASDAQ: EXEL), a biotechnology company focused on the development of drugs to treat various types of cancer, moved steadily higher by a cool 10% in July, according to data from S&P